Overview
CGTX market data
Price History
CGTX price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for CGTX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
FDA Agrees Psychosis Associated With Dementia With Lewy Bodies May Be Approvable Outcome, Reaches Alignment With Cognition Therapeutics On Vital Aspects To Support Its New Drug ApplicationBenzinga · Jun 24, 2026, 11:45 AM
8-K filing — COGNITION THERAPEUTICS INC (CGTX)SEC EDGAR · Jun 24, 2026, 11:39 AM
Cognition Therapeutics Receives Notice Of Allowance From USPTO For Patent Application 19/563,468, Covering Polymorphic Crystalline Form Of ZervimesineBenzinga · Jun 16, 2026, 11:40 AM
Cognition Therapeutics Discloses May 20 Meeting With FDA To Review Results From Its Phase 2 Study Of Zervimesine And Discuss Design And Endpoints Of A Study In Dementia With Lewy Bodies Patients With PsychosisBenzinga · May 21, 2026, 11:45 AM
Cognition Therapeutics Announces Second Philanthropic Donation From A Participant In The Ongoing Expanded Access Program For People With Dementia With Lewy BodiesBenzinga · May 14, 2026, 11:34 AM